{"id":320478,"date":"2026-10-21T14:01:46","date_gmt":"2026-10-21T08:31:46","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/"},"modified":"2026-10-21T14:01:46","modified_gmt":"2026-10-21T08:31:46","slug":"nureca-q2-results-fy27-pat-4-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/","title":{"rendered":"Nureca Q2 Results FY27: PAT Rises 11.57% to Rs 4.05 Cr, Revenue Rs 58.53 Cr"},"content":{"rendered":"<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Nureca Q2 Results FY27 were declared on 21 October 2026 as quarterly results on a consolidated basis. Revenue rose 55.09% YoY to Rs 58.53 Cr, while net profit increased 11.57% YoY to Rs 4.05 Cr. The results date and YoY growth point to a stronger top line, with consolidated results also showing Operating Profit at Rs 5.23 Cr.<\/p>\n<\/div>\n<p><a href=\"https:\/\/univest.in\/stocks\/nureca\/nureca-ltd-share-price-today\">Nureca Ltd<\/a> (NURECA) Q2 Results FY27 announced on 21 October 2026, covering the company&#8217;s financial performance for the July to September 2026 quarter. Nureca Q2 Results FY27 showed consolidated revenue of Rs 58.53 Cr, up from Rs 37.74 Cr a year earlier, while net profit came in at Rs 4.05 Cr versus Rs 3.63 Cr in the same quarter last year. The results date and consolidated results basis are central to the comparison.<\/p>\n<p>Nureca Q2 Results adds a clear results analysis view for investors tracking the company on NSE and BSE. This article covers the financial highlights, business drivers, outlook and risks, and then connects the quarterly results to the next set of disclosures that matter for Nureca and Univest readers.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=quarterly_results\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#Nureca_Q2_Results_FY27_Financial_Highlights\" title=\"Nureca Q2 Results FY27: Financial Highlights\">Nureca Q2 Results FY27: Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#Key_Takeaways_from_Nureca_Q2_Results_What_Stands_Out\" title=\"Key Takeaways from Nureca Q2 Results: What Stands Out\">Key Takeaways from Nureca Q2 Results: What Stands Out<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#Nureca_Q2_Results_FY27_Performance_Analysis\" title=\"Nureca Q2 Results FY27: Performance Analysis\">Nureca Q2 Results FY27: Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#Key_Business_Factors_This_Quarter\" title=\"Key Business Factors This Quarter\">Key Business Factors This Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#FY27_Outlook_After_Nureca_Q2_Results\" title=\"FY27 Outlook After Nureca Q2 Results\">FY27 Outlook After Nureca Q2 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#Key_Risks_to_Watch_After_Nureca_Q2_Results_FY27\" title=\"Key Risks to Watch After Nureca Q2 Results FY27\">Key Risks to Watch After Nureca Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#Margin_pressure\" title=\"Margin pressure\">Margin pressure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#Return_profile\" title=\"Return profile\">Return profile<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#Capital_efficiency\" title=\"Capital efficiency\">Capital efficiency<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#Frequently_Asked_Questions_on_Nureca_Q2_Results_FY27\" title=\"Frequently Asked Questions on Nureca Q2 Results FY27\">Frequently Asked Questions on Nureca Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#What_are_Nureca_Q2_Results_FY27\" title=\"What are Nureca Q2 Results FY27?\">What are Nureca Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#What_is_the_results_date_for_Nureca_Q2_Results_FY27\" title=\"What is the results date for Nureca Q2 Results FY27?\">What is the results date for Nureca Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#What_revenue_was_reported_in_Nureca_Q2_Results_FY27\" title=\"What revenue was reported in Nureca Q2 Results FY27?\">What revenue was reported in Nureca Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#What_net_profit_was_reported_in_Nureca_Q2_Results_FY27\" title=\"What net profit was reported in Nureca Q2 Results FY27?\">What net profit was reported in Nureca Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#How_much_YoY_growth_did_revenue_show_in_Nureca_Q2_Results_FY27\" title=\"How much YoY growth did revenue show in Nureca Q2 Results FY27?\">How much YoY growth did revenue show in Nureca Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#Did_net_profit_rise_or_fall_in_Nureca_Q2_Results_FY27\" title=\"Did net profit rise or fall in Nureca Q2 Results FY27?\">Did net profit rise or fall in Nureca Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#What_was_the_Operating_Profit_in_Nureca_Q2_Results_FY27\" title=\"What was the Operating Profit in Nureca Q2 Results FY27?\">What was the Operating Profit in Nureca Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#What_business_factors_shaped_Nureca_Q2_Results_FY27\" title=\"What business factors shaped Nureca Q2 Results FY27?\">What business factors shaped Nureca Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#What_are_the_key_risks_after_Nureca_Q2_Results_FY27\" title=\"What are the key risks after Nureca Q2 Results FY27?\">What are the key risks after Nureca Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#What_is_the_outlook_after_Nureca_Q2_Results\" title=\"What is the outlook after Nureca Q2 Results?\">What is the outlook after Nureca Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q2-results-fy27-pat-4-crore\/#Where_can_I_find_the_complete_Nureca_Q2_Results_FY27_data\" title=\"Where can I find the complete Nureca Q2 Results FY27 data?\">Where can I find the complete Nureca Q2 Results FY27 data?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Nureca_Q2_Results_FY27_Financial_Highlights\"><\/span><strong>Nureca Q2 Results FY27: Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q2 FY27 (Sep 26)<\/th>\n<th>Q2 FY26 (Sep 25)<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<tr>\n<td><strong>Revenue<\/strong><\/td>\n<td>Rs 58.53 Cr<\/td>\n<td>Rs 37.74 Cr<\/td>\n<td>+55.09% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Operating Profit<\/strong><\/td>\n<td>Rs 5.23 Cr<\/td>\n<td>Rs 3.27 Cr<\/td>\n<td>+59.94% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Profit (PAT)<\/strong><\/td>\n<td>Rs 4.05 Cr<\/td>\n<td>Rs 3.63 Cr<\/td>\n<td>+11.57% YoY<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source: company filing for Nureca Q2 Results FY27, 21 October 2026. Figures in Rs Crore, Consolidated basis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways_from_Nureca_Q2_Results_What_Stands_Out\"><\/span><strong>Key Takeaways from Nureca Q2 Results: What Stands Out<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Revenue:<\/strong> Consolidated revenue rose 55.09% YoY to Rs 58.53 Cr, marking the strongest headline move in the quarter.<\/li>\n<li><strong>Net profit:<\/strong> Net profit increased 11.57% to Rs 4.05 Cr, which kept profitability moving higher alongside the top line.<\/li>\n<li><strong>Operating Profit:<\/strong> The Operating Profit line advanced 59.94% YoY to Rs 5.23 Cr, faster than net profit growth.<\/li>\n<li><strong>Results basis:<\/strong> Nureca Q2 Results FY27 were reported on a consolidated basis, so the figures reflect the wider group performance.<\/li>\n<li><strong>What to watch:<\/strong> The mix of revenue growth and profit growth makes the next results analysis important for margin and earnings follow-through.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Nureca_Q2_Results_FY27_Performance_Analysis\"><\/span><strong>Nureca Q2 Results FY27: Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Nureca Q2 Results FY27 show a quarter where revenue expanded much faster than net profit, which is useful for a direct results analysis. Consolidated revenue of Rs 58.53 Cr and net profit of Rs 4.05 Cr together show that the company delivered higher sales and higher earnings in the July to September 2026 quarter.<\/p>\n<p>On the operating side, Operating Profit rose to Rs 5.23 Cr from Rs 3.27 Cr a year ago, a 59.94% YoY growth rate that was stronger than revenue growth. Nureca Q2 Results therefore show that the quarter was not only about scale, but also about the profit line named in the filing.<\/p>\n<p>For investors, the next focus in the quarterly results sequence is whether this pace can continue in the following disclosures. The current numbers confirm the results, and the business factors section explains the disclosed drivers behind the latest quarter, which is where the results analysis turns next.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live results data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_This_Quarter\"><\/span><strong>Key Business Factors This Quarter<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Revenue growth<\/strong> &#8211; Revenue grew 55.1% year on year to Rs 58.53 Cr in the latest quarter. That move is the clearest disclosed factor in the quarterly results and it anchors the revenue line in Nureca Q2 Results FY27.<\/p>\n<p><strong>Net profit improvement<\/strong> &#8211; Net profit rose 11.6% year on year to Rs 4.05 Cr. This shows that profit moved higher too, although at a slower pace than revenue, which is important in the results analysis.<\/p>\n<p><strong>Balance sheet position<\/strong> &#8211; The company is almost debt free, with a debt-to-assets ratio of 0.00 in FY26. That balance sheet detail adds context to the quarter and is one of the few company-specific notes supplied for Univest readers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_After_Nureca_Q2_Results\"><\/span><strong>FY27 Outlook After Nureca Q2 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The FY27 outlook after Nureca Q2 Results should be read as a continuation of the results analysis rather than a management forecast. The supplied data shows strong quarterly results, but the full-year path will depend on subsequent quarters and the disclosed sector conditions, along with how net profit trends from here.<\/p>\n<p>Nureca Q2 Results FY27 therefore provide a current-quarter reference point for the rest of the year. For Univest readers, the key issue is whether the revenue base and the operating Profit line can hold similar momentum in the coming quarters, which leads directly into the risks that should be watched.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Watch_After_Nureca_Q2_Results_FY27\"><\/span><strong>Key Risks to Watch After Nureca Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Margin_pressure\"><\/span><strong>Margin pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Net profit margin narrowed to 6.9% from 9.6% in the comparison quarter. That change matters because YoY growth in revenue did not fully translate into the same pace of net profit growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Return_profile\"><\/span><strong>Return profile<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Return on equity was low at 1.11% in FY26. The figure does not affect the quarterly results already reported, but it remains a risk marker for the broader results analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Capital_efficiency\"><\/span><strong>Capital efficiency<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Return on capital employed was modest at 3.31% in FY26. Together with the annual earnings trend, this is a reminder that Nureca Q2 Results should be read alongside the next quarter&#8217;s YoY growth and operating performance.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track quarterly results as they are declared.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Nureca Q2 Results FY27 show a consolidated quarter with higher revenue, higher Operating Profit and higher net profit on a YoY basis. The quarterly results point to a better top line and a firmer profit line, but investors should read the results basis, profit trend and risk markers together before acting and consult a SEBI-registered advisor.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Nureca_Q2_Results_FY27\"><\/span><strong>Frequently Asked Questions on Nureca Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_are_Nureca_Q2_Results_FY27\"><\/span><strong>What are Nureca Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nureca Q2 Results FY27 are the company&#8217;s consolidated quarterly results for July to September 2026, with revenue of Rs 58.53 Cr and net profit of Rs 4.05 Cr. They are detailed in the Financial Highlights table and the performance analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_results_date_for_Nureca_Q2_Results_FY27\"><\/span><strong>What is the results date for Nureca Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nureca Q2 Results FY27 were announced on 21 October 2026. The results date is used throughout the article to anchor the quarterly results and the consolidated results basis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_revenue_was_reported_in_Nureca_Q2_Results_FY27\"><\/span><strong>What revenue was reported in Nureca Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nureca reported revenue of Rs 58.53 Cr in Q2 FY27, compared with Rs 37.74 Cr in the same quarter last year. This is covered in the Financial Highlights table and the results analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_net_profit_was_reported_in_Nureca_Q2_Results_FY27\"><\/span><strong>What net profit was reported in Nureca Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nureca reported net profit of Rs 4.05 Cr in Q2 FY27, up from Rs 3.63 Cr a year earlier. The same figure is referenced in the Quick Answer and the performance analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_YoY_growth_did_revenue_show_in_Nureca_Q2_Results_FY27\"><\/span><strong>How much YoY growth did revenue show in Nureca Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue showed 55.09% YoY growth in Nureca Q2 Results FY27. That increase is visible in the Financial Highlights table and is discussed again in the key takeaways section.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_net_profit_rise_or_fall_in_Nureca_Q2_Results_FY27\"><\/span><strong>Did net profit rise or fall in Nureca Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit rose in Nureca Q2 Results FY27, reaching Rs 4.05 Cr from Rs 3.63 Cr. The article links that move to the consolidated results and the performance analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Operating_Profit_in_Nureca_Q2_Results_FY27\"><\/span><strong>What was the Operating Profit in Nureca Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Operating Profit came to Rs 5.23 Cr in Nureca Q2 Results FY27, versus Rs 3.27 Cr in the prior-year quarter. This profit metric is also covered in the business factors discussion.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_business_factors_shaped_Nureca_Q2_Results_FY27\"><\/span><strong>What business factors shaped Nureca Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied business factors highlight revenue growth, net profit improvement and an almost debt-free balance sheet. These points are covered in the Key Business Factors This Quarter section.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_after_Nureca_Q2_Results_FY27\"><\/span><strong>What are the key risks after Nureca Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The key risks are margin narrowing, low return on equity and modest return on capital employed. Those points are listed in the Key Risks to Watch section and relate to YoY growth and profitability.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_outlook_after_Nureca_Q2_Results\"><\/span><strong>What is the outlook after Nureca Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The outlook after Nureca Q2 Results depends on subsequent quarters and disclosed sector conditions. The FY27 outlook section explains that the latest net profit trend should be read with caution and context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_find_the_complete_Nureca_Q2_Results_FY27_data\"><\/span><strong>Where can I find the complete Nureca Q2 Results FY27 data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The complete Nureca Q2 Results FY27 data appears in the Financial Highlights table and the surrounding analysis. That section gives the quarter figures, YoY growth and the consolidated results basis in one place.<\/p>\n<\/p>\n<p><script type=\"application\/ld+json\" class=\"faq-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are Nureca Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nureca Q2 Results FY27 are the company's consolidated quarterly results for July to September 2026, with revenue of Rs 58.53 Cr and net profit of Rs 4.05 Cr. They are detailed in the Financial Highlights table and the performance analysis.\"}},{\"@type\":\"Question\",\"name\":\"What is the results date for Nureca Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nureca Q2 Results FY27 were announced on 21 October 2026. The results date is used throughout the article to anchor the quarterly results and the consolidated results basis.\"}},{\"@type\":\"Question\",\"name\":\"What revenue was reported in Nureca Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nureca reported revenue of Rs 58.53 Cr in Q2 FY27, compared with Rs 37.74 Cr in the same quarter last year. This is covered in the Financial Highlights table and the results analysis.\"}},{\"@type\":\"Question\",\"name\":\"What net profit was reported in Nureca Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nureca reported net profit of Rs 4.05 Cr in Q2 FY27, up from Rs 3.63 Cr a year earlier. The same figure is referenced in the Quick Answer and the performance analysis.\"}},{\"@type\":\"Question\",\"name\":\"How much YoY growth did revenue show in Nureca Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue showed 55.09% YoY growth in Nureca Q2 Results FY27. That increase is visible in the Financial Highlights table and is discussed again in the key takeaways section.\"}},{\"@type\":\"Question\",\"name\":\"Did net profit rise or fall in Nureca Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Net profit rose in Nureca Q2 Results FY27, reaching Rs 4.05 Cr from Rs 3.63 Cr. The article links that move to the consolidated results and the performance analysis.\"}},{\"@type\":\"Question\",\"name\":\"What was the Operating Profit in Nureca Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Operating Profit came to Rs 5.23 Cr in Nureca Q2 Results FY27, versus Rs 3.27 Cr in the prior-year quarter. This profit metric is also covered in the business factors discussion.\"}},{\"@type\":\"Question\",\"name\":\"What business factors shaped Nureca Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The supplied business factors highlight revenue growth, net profit improvement and an almost debt-free balance sheet. These points are covered in the Key Business Factors This Quarter section.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks after Nureca Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The key risks are margin narrowing, low return on equity and modest return on capital employed. Those points are listed in the Key Risks to Watch section and relate to YoY growth and profitability.\"}},{\"@type\":\"Question\",\"name\":\"What is the outlook after Nureca Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The outlook after Nureca Q2 Results depends on subsequent quarters and disclosed sector conditions. The FY27 outlook section explains that the latest net profit trend should be read with caution and context.\"}},{\"@type\":\"Question\",\"name\":\"Where can I find the complete Nureca Q2 Results FY27 data?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The complete Nureca Q2 Results FY27 data appears in the Financial Highlights table and the surrounding analysis. That section gives the quarter figures, YoY growth and the consolidated results basis in one place.\"}}]}<\/script><br \/>\n<script type=\"application\/ld+json\" class=\"news-article-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Nureca Q2 Results FY27: PAT Rises 11.57% to Rs 4.05 Cr, Revenue Rs 58.53 Cr\",\"description\":\"Nureca Q2 Results: Consolidated revenue \u20b958.53 Cr, PAT \u20b94.05 Cr. Check YoY growth and quarterly results analysis from the 21 October 2026 filing.\",\"author\":{\"@type\":\"Organization\",\"name\":\"Univest\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Univest\",\"url\":\"https:\/\/univest.in\"},\"about\":{\"@type\":\"Corporation\",\"name\":\"Nureca Ltd\"}}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nureca Q2 FY27 results show revenue of Rs 58.53 Cr and PAT of Rs 4.05 Cr on a consolidated basis.<\/p>\n","protected":false},"author":29,"featured_media":320477,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-320478","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["320477"],"rank_math_title":["Nureca Q2 Results FY27: PAT Rises 11.57% to Rs 4.05 Cr"],"rank_math_description":["Nureca Q2 Results: Consolidated revenue \u20b958.53 Cr, PAT \u20b94.05 Cr. Check YoY growth and quarterly results analysis from the 21 October 2026 filing."],"rank_math_focus_keyword":["Nureca Q2 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/nureca-q2-results-fy27-pat-rises-11-57-to-rs-4-05-cr-revenue-rs-58-53-cr.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/320478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=320478"}],"version-history":[{"count":0,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/320478\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/320477"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=320478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=320478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=320478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}